Genex ApS: Financial statements 2025
CVR: 42881112
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Genex ApS (CVR 42881112) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -1,500 and a net result of DKK -1,500 compared with DKK -1,434 the year before. Equity in the 2025 report amounted to DKK 21,713. The solvency ratio was 88%.
- Gross Profit
- DKK -1,500
- Profit/Loss
- DKK -1,500
- Equity
- DKK 21,713
- Total Assets
- DKK 24,686
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -2 t. | -2 t. | 22 t. | - |
| 2024 | - | -2 t. | -1 t. | 23 t. | - |
| 2023 | - | -6 t. | -6 t. | 25 t. | - |
| 2022 | - | -9 t. | -9 t. | 31 t. | - |
How creditworthy is Genex ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Genex ApS has published its annual report for 2024. Gross profit came to DKK -1,500, and the net result was DKK -1,434.
About Genex ApS
Genex ApS is a Danish company of the type Anpartsselskab based in Holbæk, founded in 2021. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The management consists of Lone Majbritt Christiansen. The company is owned by Lone Majbritt Christiansen. In 2025, the company reported a gross profit of DKK -1,500 and a net result of DKK -1,500 compared with DKK -1,434 the year before. Equity in the 2025 report amounted to DKK 21,713.